Join DefiniGEN (Booth 3) at TIDES: Oligonucleotides and Peptide Therapeutics 2019, the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development and commercialization.
DefiniGEN invites all TIDES 2019 attendees wanting to discover more about how its range of human cell products and services can be used in disease modelling and drug discovery applications to visit booth #3.
Contact us to arrange a meeting at TIDES 2019
- TIDES is the most comprehensive event for the therapeutics industry. With over 1,000 scientists, engineers, and executives in attendance, and the only agenda with full coverage of discovery, development, and manufacturing.
- Over 1000 oligonucleotide and peptide scientists will be present.
- Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.
- With 125+ case studies and new data presentations, you are bound to hear the best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.
To learn more about the conference, visit TIDES’ official event page.